Autoimmune and Immunodeficiency Diseases

  • Hugh R. K. Barber


Ovarian cancer often resembles an autoimmune disorder. These patients may be difficult to cross-match, and it has been observed that they have an antibody that interferes with cross-matching. Such an antibody, which may occur in patients who have not been transfused, reacts against normal tissue but does not recognize the ovarian cancer antigen. It can be suppressed after cortisone treatment. For 2 to 3 days following this therapy it is possible to cross-match the patient. In addition, the use of anticancer drug treatment gives the patient a sense of well-being long before there is any effect on tumor volume. These observations are suggestive but not conclusive that an autoimmune disorder results from the ovarian cancer.


Ovarian Cancer Immune Complex Recurrent Ovarian Cancer Primary Immunodeficiency Disease DiGeorge Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allison AC: Unresponsiveness to self-antigens. Lancet 2: 1401, 1971.PubMedCrossRefGoogle Scholar
  2. Allison AC, Denman AM, Barnes RD: Cooperating and controlling function of thymus-derived lymphocytes in relation to autoimmunity. Lancet 2: 135, 1971.PubMedCrossRefGoogle Scholar
  3. Altman A, Cohen IR, Feldman M: Normal T cell receptors for alloantigens. Cell Immunol 7: 134, 1973.PubMedCrossRefGoogle Scholar
  4. Barber HRK: Immunobiology for the Clinician. John Wiley & Sons, New York, 1977.Google Scholar
  5. Barber HRK: The immune complex in diagnosis. Diagn Gynecol Obstet 2 (1): 3, 1980.PubMedGoogle Scholar
  6. Barber HRK: Introduction to immunology. Mt Sinai J Med 47: 427, 1980.PubMedGoogle Scholar
  7. Barnes EW, Irvine WJ: Clinical syndromes associated with thymic disorders. Proc R Soc Med 66: 151, 1973.PubMedGoogle Scholar
  8. Belohradsky BH: Meeting report of the second international workshop on primary immunodeficiency diseases in man. Clin Immunol Immunopathol 2: 281, 1974.PubMedCrossRefGoogle Scholar
  9. Bretscher P: A model for generalized autoimmunity. Cell Immunol 6: 1, 1973.PubMedCrossRefGoogle Scholar
  10. Burnet FN: The Clonal Selection Theory of Acquired Immunity. Cambridge University Press, Cambridge, 1959.Google Scholar
  11. Burnet FN: Cellular Immunology. Cambridge University Press, Cambridge, 1970.Google Scholar
  12. Christian CL, Phillips PE: Viruses and autoimmunity. Am J Med 54: 611, 1973.PubMedCrossRefGoogle Scholar
  13. Cooper MD: Meeting report of the second international workshop on primary immunodeficiency diseases in man. Clin Immunol Immunopathol 2: 416, 1974.PubMedCrossRefGoogle Scholar
  14. Fudenberg HH, Stites DP, Caldwell JR, Wells JV: Basic and Clinical Immunology. Lange Medical Publications, Los Altos, CA, 1976.Google Scholar
  15. Gershon RK: T cell control of antibody production In Cooper MD, Warner NL (eds): Contemporary Topics in Immunology. Vol. 3. Plenum, New York, 1974.Google Scholar
  16. Glasser DL, Silvers WK: Genetic determinants of immunological responsiveness. Adv Immunol 18. 1, 1972.CrossRefGoogle Scholar
  17. Harris JE, Sirkovics JG: The Immunology of Malignant Disease. Mosby, St. Louis, 1970.Google Scholar
  18. Hemet R, McKern T (eds): Monoclonal Antibodies. Plenum Press, New York, 1980.Google Scholar
  19. Kohler G, Millstein C: Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256: 495, 1975.PubMedCrossRefGoogle Scholar
  20. Levy JA: Autoimmunity and neoplasia: the possible role of C-type viruses. Am J Clin Pathol 62: 258, 1974.PubMedGoogle Scholar
  21. Marx JL: Slow viruses: role in persistent disease. Science 181: 1351, 1973.CrossRefGoogle Scholar
  22. McDevitt HO, Bodner WF: Histocompatibility antigens, immune responsiveness and susceptibility to disease. Am J Med 52: 1, 1972.PubMedCrossRefGoogle Scholar
  23. Millstein C: Monoclonal antibodies. Sci Am 243 (4): 66, 1980.CrossRefGoogle Scholar
  24. Paterson PY: Multiple sclerosis: an immunologic reassessment. J Chronic Dis 26: 119, 1973.PubMedCrossRefGoogle Scholar
  25. Rowley DA: Specific suppression of immune responses. Science 181: 1133, 1973.PubMedCrossRefGoogle Scholar
  26. Siegel MM, Good RA (eds): Tolerance, Autoimmunity and Aging. Charles C Thomas, Springfield, IL, 1972.Google Scholar
  27. Steinberg AD, Baron S, Talal N: The pathogenesis of autoimmunity in New Zealand mice: induction of antinucleic acid antibodies by polymosinic polycytidylic acid. Proc Natl Acad Sci USA 63: 1102, 1969.PubMedCrossRefGoogle Scholar
  28. Stutman O: Lymphocyte subpopulations in NZB mice: deficit of thymus dependent lymphocytes. J Immunol 109: 602, 1972.PubMedGoogle Scholar
  29. Thomas L: Experimental mycoplasma infections as models of rheumatoid arthritis. Fed Proc 32: 143, 173.Google Scholar
  30. Wybran JL, Levin AS, Spitler LE, Tudenberg HH: Rosette-forming cells, immunological deficiency diseases and transfer factor. N Engl J Med 288: 710, 1973.PubMedCrossRefGoogle Scholar
  31. Yaltan DE, Roberts SB, Scharff MD: Hybridomas and monoclonal antibodies. Lab Management 19 (1): 19, 1981.Google Scholar

Copyright information

© Springer-Verlag New York, Inc. 1993

Authors and Affiliations

  • Hugh R. K. Barber
    • 1
  1. 1.Department of Obstetrics and GynecologyLenox Hill HospitalNew YorkUSA

Personalised recommendations